Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;56(11):3179-86.
doi: 10.1007/s10620-011-1730-y. Epub 2011 May 12.

Effects of Bifidobacterium Infantis 35624 on Post-Inflammatory Visceral Hypersensitivity in the Rat

Affiliations

Effects of Bifidobacterium Infantis 35624 on Post-Inflammatory Visceral Hypersensitivity in the Rat

Anthony C Johnson et al. Dig Dis Sci. .

Abstract

Background: Irritable bowel syndrome patients have abnormal visceral perception. Probiotic organisms may produce beneficial effects in these patients by reducing visceral hypersensitivity.

Aim: To investigate the effects of the probiotic organism, Bifidobacterium infantis 35624, on post-inflammatory visceral hypersensitivity in rats.

Methods: Colitis was induced using intracolonic administration of trinitrobenzenesulfonic acid; control rats received saline (day 0). Myeloperoxidase (MPO) levels and colonic damage scores were determined. From days 15-29, rats (n = 10/group) rats were orally dosed with 2 ml of B. infantis ≥ 10(8) colony-forming units/ml or vehicle (MRS broth). A second series of rats (n = 10/group) was dosed in the same manner from days 15-59. The level of colonic stimulation during colorectal distension (CRD) was determined by recording a visceromotor response (VMR) to CRD at 30 mmHg pre- and post-treatment. Post-treatment samples of colonic tissue were weighed, graded for morphologic damage, and assayed for MPO levels.

Results: All rats were hypersensitive at day 15. On day 30, hypersensitivity to colorectal distension remained in the vehicle group, but was significantly reduced in the B. infantis group (mean VMR/10 min: vehicle = 15.4 ± 1.0 vs. B. infantis = 7.6 ± 1.0, p < 0.001). A similar, significant effect was observed at day 60. On both day 30 and day 60, tissue weight, colonic damage scores, and MPO levels resembled those of control animals.

Conclusions: Oral administration of Bifidobacterium infantis 35624 normalized sensitivity to colorectal distension in a rat model of post-inflammatory colonic hypersensitivity.

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles

References

    1. Clin Exp Pharmacol Physiol. 2009 Oct;36(10):1034-40 - PubMed
    1. Gut. 2006 Aug;55(8):1090-4 - PubMed
    1. Gut. 2006 Feb;55(2):182-90 - PubMed
    1. Eur J Pharmacol. 1994 May 12;257(1-2):181-7 - PubMed
    1. Dig Dis Sci. 2008 Nov;53(11):2909-16 - PubMed

Publication types

LinkOut - more resources

Feedback